Current and Prospective Pharmaceutical Use of Algal Bioproducts (2025)

What is Open Access?

Open Access is an initiative that aims to make scientific research freely available to all. To date our community has made over 100 million downloads. It’s based on principles of collaboration, unobstructed discovery, and, most importantly, scientific progression. As PhD students, we found it difficult to access the research we needed, so we decided to create a new Open Access publisher that levels the playing field for scientists across the world. How? By making research easy to access, and puts the academic needs of the researchers before the business interests of publishers.

Authors, Editors and Institutions

We are a community of more than 103,000 authors and editors from 3,291 institutions spanning 160 countries, including Nobel Prize winners and some of the world’s most-cited researchers. Publishing on IntechOpen allows authors to earn citations and find new collaborators, meaning more people see your work not only from your own field of study, but from other related fields too.

Content Alerts

Brief introduction to this section that descibes Open Access especially from an IntechOpen perspective

How it Works Manage preferences

Contact

Want to get in touch? Contact our London head office or media team here

Careers

Our team is growing all the time, so we’re always on the lookout for smart people who want to help us reshape the world of scientific publishing.

Home > Books > Algae Science and Applications [Working Title]

Current and Prospective Pharmaceutical Use of Algal Bioproducts (2)Open access peer-reviewed chapter - ONLINE FIRST

Written By

Edwin H.W. Leung

Submitted: 07 January 2025 Reviewed: 04 February 2025 Published: 13 March 2025

DOI: 10.5772/intechopen.1009486

Current and Prospective Pharmaceutical Use of Algal Bioproducts (3)

Algae Science and Applications

Edited by Ihana Aguiar Severo

From the Edited Volume

Algae Science and Applications [Working Title]

Dr. Ihana Aguiar Severo

Chapter metrics overview

4 Chapter Downloads

View Full Metrics

Abstract

This chapter explores the diverse applications of algal biocompounds in human health, focusing on dietary, cosmetic, and pharmaceutical uses. Algae, ranging from macroscopic kelp to microscopic single-celled organisms (including cyanobacteria), are a rich source of bioactive compounds with potential benefits for human health and well-being. This chapter begins by classifying algae and highlighting their historical use as food. It then delves into the current and prospective applications of algal biocompounds, dividing the discussion into three main sections. The first section examines the dietary uses of algae as food supplements and additives, focusing on their role as sources of macro- and micronutrients, natural colourings, thickeners and prebiotics. The second section explores the external use of algal extracts in cosmetics, discussing their applications in anti-aging, whitening, moisturizing, thickening, photoprotection, antioxidant activity and hair care. Finally, the third section investigates the pharmaceutical potential of algal biocompounds, examining their antimicrobial, anti-inflammatory activities, hypertension management, direct cancer treatment and indirect aids, and diagnostic use. This chapter aims to provide a comprehensive overview of the current state of research and commercial applications of algal biocompounds in human health, highlighting their potential to contribute to sustainable food solutions, enhance cosmetic products, and develop novel pharmaceuticals.

Keywords

  • microalgae
  • macroalgae
  • supplement
  • food
  • cosmetics
  • pharmaceuticals
  • medicine
  • Chlorella
  • Spirulina

Author Information

Show +

  • Edwin H.W. Leung*

    • University of Warwick, Coventry, UnitedKingdom

*Address all correspondence to: edwin.leung@warwick.ac.uk

1. Introduction

Algae are predominantly aquatic, simple and eukaryotic (nucleated) plants that range from macroscopic kelp to microscopic single-cellular algae. They belong to the kingdom Protista, which can be further divided into seven taxa: Chlorophyta (green algae), Charophyta (stoneworts), Euglenophyta (euglenas), Chrysophyta (golden-brown, yellow-green algae and diatoms), Phaeophyta (brown algae), Pyrrophyta (dinoflagellates), and Rhodophyta (red algae) [1]. Despite the taxonomical classification, for the purpose of a more holistic discussion of the “algae” commonly referred to, this chapter will also include the prokaryotic cyanobacteria, that is, the blue-green algae. In fact, there are a lot of active biocompounds that are present in the blue-green algae, in which the coming sections will explore in detail.

In addition to the above scientific classification into the seven taxa, algae are more commonly classified broadly according to their sizes – complex multicellular macroalgae and smaller unicellular microalgae. Macroalgae like kelp had been found consumed directly to supplement the diets of ancient Peruvians who lived in Pampa along the coast of Peru dating back to 2500B.C. [2]. Microalgae like Nostoc spp., at the other end of the size spectrum, had already been consumed by the Chinese over 2000years ago as a type of food [3].

These photosynthetic organisms are gaining increasing attention as a sustainable and nutritious food source due to their unique nutritional profile and potential for large-scale cultivation. They are abundant in proteins, vitamins, minerals, antioxidants, etc., making them a crucial component of human diets. The United Nations World Food Conference in 1974 even declared Spirulina as the best food for the future, because of their richness in iron and protein and safeness to children [4], on top of their nutritious nature.

Commercialized algal products were first available in the late 1960s and early 1970s. Spirulina produced in Lake Texcoco was reported to be the first commercial product for human consumption [5]. Chlorella, a green alga commonly seen in the market today, was also reported to be used as a protein supplement on other side of the Pacific in Japan in the 1960s [6]. Numerous other brands of products in the market are available nowadays, and some well-known examples include β-carotene, astaxanthin and lutein.

Despite the wide variety of algae present in the world and more than 50years of exploration, to date, not many species of algae have been successfully cultivated for food or other commercial applications. Apart from the Spirulina and Chlorella we have mentioned, some other species under research and trials are Haematococcus spp., Dunaliella spp., Botryococcus spp., Phaeodactylum spp. and Porphyridium spp. [7].

Nowadays, with the advancement in biotechnologies in the twentieth century, algal biomass and their bioproducts extend beyond just being food and have been used in a diverse variety of industries. For example, they are being used as feedstock for renewable energy production due to their very short growth cycle [8], industrial materials such as bioplastics and production of biohydrogen [9], alternative biological agents in wastewater treatment [10] and so forth, which would be discussed in other chapters.

This chapter will focus on the current applications as well as prospective use of those algal biocompounds in humans, further divided into three sections according to the application of the biocompounds, namely dietary, cosmetical and pharmaceutical uses. The common algae species for each of the applications will also be discussed.

Advertisement

2. Dietary use as food supplements and additives

In an era where sustainable and nutritious food solutions are essential, algae have emerged as a promising resource for both food supplements and additives. These diverse aquatic organisms, ranging from microscopic microalgae to large seaweeds, are rich in valuable nutrients and bioactive compounds. Their unique advantages, particularly their rapid growth and short lifecycles, position algae as one of the key contributors to addressing global challenges related to food security and health. This section will explore the various applications of algae and their biocompounds in the food industry.

2.1 Food supplements

Food supplements are concentrated nutrients that are essential or beneficial to the human body. They are usually in the form of pills, tablets, capsules or liquids, depending on their inherited characteristics, and are designed to be easy and convenient for consumption. Legally, they are situated in between food and medicine and are usually regulated as food in many countries, for example in the European Union. Algae and microalgae, demonstrated to possess diverse health benefits, together with the fact that they are generally recognized as safe for their long history as food, are one of the major sources of food supplements nowadays.

Currently, commercialized microalgal products are presented in many forms. They are sometimes marketed as health food alone, usually in the forms of tablets, capsules and liquids [11]; or the algae and/or their extracts could be blended into different foods such as pastes, snacks, candy, noodles, beverages, breakfast cereals, etc. [12, 13, 14]. To date, Spirulina sp. and Chlorella sp. remain the most widely used algal species in food, along with a few other species such as Aphanizomenon flosaquae, Dunaliella salina and Dunaliella tertiolecta [3].

2.1.1 Source of macronutrients

The first generation of algae-based food supplements, developed during the mid-twentieth century food crisis, primarily focused on providing macronutrients such as proteins and fatty acids [15]. Algae possess a competitive advantage of fast and cost-effective photosynthetic growth, primarily due to their capability to be grown in high biomass concentration. This trail greatly boosts the overall solar-to-biomass conversion efficiency in some strains of algae and results in a 16-fold increase in biomass when compared to terrestrial corn grown in the same amount of land [16]. Another study by Ullah et al. even found that algae can produce a maximum of about 160 times biomass more than corn, despite being in very confined conditions [17].

On top of normal biomass, many algae species are found capable of yielding very high levels of desired nutrients under cultivation. Chlorella spp., one of the most widely cultivated species, was reported to produce a maximum of about 65% of protein in dry weight [18]. Spirulina spp., another commonly harvested algae nowadays, on the other hand yet similarly, had been found to have a maximum protein level of 60–70% in dry weight, significantly higher than all common meat and fish (by contrast, beef contains about 22% protein in dry weight) [19]. Further, unlike most of the ordinary plant-based proteins, proteins derived from algae have a comprehensive profile thanks to the presence of both essential and non-essential amino acids in sufficient quantities.

In addition, the role of algae in food production, especially for protein, is becoming increasingly prominent in the current era of climate change. Currently, the livestock supply chain – the traditional protein production – alone accounts for about 14.5% of total greenhouse gas emissions worldwide [20], because of its inefficient energy transfer across three trophic levels. Contrastingly, being an autotroph, algal-based proteins are comparingly much sustainable, and the proteins are foreseen to be one of the major players in alternative protein production in the near future [21].

Despite all these outstanding features, algae do have limitations that hinder commercialization as a major food source. The greatest obstacle is the unreasonably high cost of harvesting, which alone could account for up to 30% of total production cost, due to high energy demand and capital cost. Common harvesting methods at the time involved filtration, centrifugation, flocculation, and flotation, or a combination of the above methods [22]. It was only with technological advancements and cost reductions since the 1960s that microalgal products began to be used as food supplements worldwide.

Amazingly, microalgae species can be engineered the other way around to have relatively low protein levels while being high in lipid content. Unlike typical macroalgae seaweed that contains only 2–4.5% of lipids (in the form of glycolipids and phospholipids) in their dry weight, microalgae could be manipulated to contain from around 20–50% to as high as 80% of lipids, under specific and optimized culturing conditions [22]. The main drawback of algal lipid production maybe its high water consumption, with an estimated requirement of over 3700kg of water for every 1kg of lipid produced. The huge consumption, however, could be reduced significantly, as 90% of wastewater produced could be recycled for algae cultivation [23]. Currently, algal lipids are primarily used for oil or biodiesel production, rather than for human consumption and applications discussed in this chapter.

Despite the absence of commercial dietary supplements solely based on algal lipids, algae, especially microalgae, were found to produce various forms of essential fatty acids, such as Omega-3 and Omega-6 including the most popular and widely commercialized eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), alongside with linoleic acid, gamma-linolenic acid, arachidonic acid, and more [24]. These fatty acids are well-known for significantly enhancing human health by lowering the possibility of cardiovascular diseases and hypertension, inflammation regulation, and brain development, just to name a few. Microalgae such as Nannochloropsis spp., Tetraselmis spp. and some others are capable of mass producing such essential fatty acids for human consumption in a relatively large quantity and sustainable manner [25].

2.1.2 Source of micronutrients

More than macronutrients, algae were found to contain abundantly many types of micronutrients like vitamins and minerals. For instance, studies showed that microalgae were excellent sources of vitamins (A, B1, B2, B12, C and E), iodine, potassium, iron, magnesium and calcium [3]. However, to the best effort of the author, there is no standalone commercial micronutrient supplement on the market advertised as being naturally extracted from algae. All these products are marketed as whole algae that contain rich amounts of advertised micronutrients. This is probably because of the relatively high price of purifying such micronutrients and the availability of alternative inexpensive sources elsewhere.

2.2 Food additives

2.2.1 Colourings

Algae serve as a valuable source of natural food colourings, with chlorophylls, carotenoids, and phycobiliproteins being the most commonly used additives in the food industry.

Chlorophylls are a group of green pigments naturally produced by various types of both macroalgae and microalgae for photosynthesis, alongside many terrestrial plants. Contrary to their biological function of absorbing photons, purified chlorophylls are surprisingly rather unstable and easily degraded by light, acid, base and oxidants. In order to maintain their colour stably, food industries often use chlorophyllide, a slightly modified form of chlorophyll, as a colouring agent [26]. While almost all plants contain chlorophyll, algae especially Spirulina spp., contain much higher content of chlorophylls (a and b), up to three times that of other plants [27], rendering them an economic source of chlorophylls for production of chlorophyllide in the industry.

Carotenoids are a diverse group of approximately 500 unsaturated hydrocarbons that frequently serve as accessory pigments in the light-harvesting process within chloroplasts [28]. They are widely presented in many algal taxa in high amounts, for instance, Chlorophyta, Rhodophyta, Phaeophyta, Dinoflagellate [29]. Carotenoids supplement chlorophylls and hence strongly absorb wavelengths they leave behind, that is, 400–600nm, and thus appear red to yellow in colour. Common carotenoids that are isolated from algae include β-carotene, astaxanthin, lutein and zeaxanthin, and all of them have high potential to be used as food colourings. However, carotenoids extracted from algae have not yet been widely used nowadays due to their stability and technological constraints [26].

Phycobiliproteins are another very important photosynthetic accessory pigments found commonly in blue-green algae (e.g., blue phycocyanin and light-blue allophycocyanin) and red algae (e.g., red phycoerythrobilin) [30]. Their bright colour and high yield make them another ideal colourings in the food industry. Most research to date focuses on the application of phycocyanin extracted from Spirulina spp., while phycobiliproteins from other algae also carry high potentials [31]. Notably, blue phycocyanin, among its other wide applications, is the only blue dye officially approved by the United States Food and Drug Administration (USFDA) to be used in foods and cosmetics [32]. Moreover, the proteins were also found to possess antioxidant, antiviral, anti-cancer, antiallergic, anti-inflammatory, and neuroprotective characteristics, with high potential to be further researched in healthcare applications [33]. The proteins’ pharmaceutical functions will be further discussed in Section 4.

2.2.2 Thickeners

An important application of algae in the food industry is thickeners. Thickeners are defined by the USFDA as “substances used to produce viscous solutions or dispersions, to impart body, improve consistency, or stabilize emulsions” [34]. Polysaccharides extracted from macroalgae seaweeds are highly regarded by the industry as excellent thickeners, enhancing water absorption and texture in various products, including confectionery, dairy, desserts, bakery, meat and dressings [35]. The polysaccharides are mainly extracted from brown and red algae, and the polysaccharides commonly used include alginate (or algin), agar and carrageenan.

Alginates are a group of structurally similar copolymers composed of two main building blocks - mannuronic and guluronic acids. The ratio and distribution of the two blocks influence the physical properties of the alginate gel, such as its strength and elasticity. They are found in the cell walls of brown algae, enhancing their flexibility. Today, alginates are commonly extracted from brown algae including Ascophyllum spp., Laminaria spp., Lessonia spp. and Macrocystis spp. [28]. It was also reported that the alginate content increases in those algae that grow in more turbulent regions [36]. With its low gelation temperature, alginates are a popular choice of thickener in jam and pulp/paste in a wide variety of food. Nowadays, alginate is one of the most widely used thickeners in products for instance dairy and meat products [28].

Agar is another polysaccharide extracted from algae with similar functions as alginates. However, agar is extracted from the cell walls of red instead of brown algae. Common species suitable for extraction include Gelidium spp. and Gracilaria spp. [37]. While it may not affect too much the choice of food manufacturers, the most notable difference between agar and alginate is that the former is thermo-reversible whilst alginate is irreversible [38]. Likewise, agar is also widely applied in diverse types of food, for example, dairy products (e.g., cheese, cream, milk deserts, yoghurt), cereal-based products and even some meat products [37].

Carrageenan is a family of linear sulfated polysaccharides with molecular sizes between 200 and 800kDa [39]. Commercially, three types of carrageenan are commonly used, namely κ-Carrageenan (Kappa), ι-Carrageenan (Iota) and λ-Carrageenan (Lambda) [40]. They are regarded as ‘Generally Recognized as Safe’ in both the United States and Europe and have been widely used in commercialized food such as ice creams, chocolate milk, pudding, condensed milk and more. More than thickeners, carrageenan is also used as a gelling, water-holding, stabilizing, and emulsifying agent in the food industry. Recently, their potential use in mimicking meat products by binding meat-free ingredients for vegetarians is also explored [39]. The multi-purpose polysaccharides could be extracted from a variety of red algae for instance Kappaphycus alvarezii, Eucheuma denticulatum, Chondrus crispus and Sarcothalia crispate [41].

2.2.3 Prebiotics

Prebiotics are food substances that resist digestion in the upper gastrointestinal tract. These non-digestible substances then reach the lower tract particularly the colon where they are selectively fermented by beneficial gut bacteria, like bifidobacteria and lactobacilli [42]. The fermentation process promotes the growth and activity of these beneficial microflora, leading to the production of short-chain fatty acids like butyrate, acetate and propionate. These fatty acids in return provide various health benefits, including improved gut barrier function, reduced inflammation and modulation of the immune system [43]. Algal products are gaining recognition as promising prebiotics due to the presence of unique non-digestible polysaccharides. These polysaccharides are present in many algae in high quantities. With many of them under intense research, a few polysaccharides were recognized scientifically for their activity, which include galacto-oligosaccharides, agar or agarose-derived oligosaccharides, xylo-oligosaccharides, alginate-derived oligosaccharides [44]. The incorporation of algal products into the diet can therefore serve as a natural strategy to support a healthy gut microbiota and overall well-being.

Advertisement

3. External use as cosmetics

Cosmetics are defined as articles intended to be applied to the human body, for various aesthetic purposes, including cleansing, beautifying, promoting attractiveness or altering the appearance. They could also be applied to the human body by various methods such as rubbing, pouring, sprinkling spraying, etc. [45]. Many algae species contain biocompounds with beneficial cosmetic properties and are used in cosmetic products. Historically used for thousands of years, algae are considered generally safe with minimal cytotoxicity to humans [46]. Additionally, the use of algal ingredients in cosmetics perfectly aligns with the current trend of naturalness in human use of bioproducts [47], and is often heavily advertised today by various brands.

The vast amount of different bioactive compounds had been successfully isolated from various algae suitable for cosmetical use, with examples including polysaccharides, sulfated polysaccharides, pigments, polyphenols, phenolic compounds, bioactive peptides, proteins, mycosporine-like amino acids, etc., [48]. In Europe alone, at least 29 patents related to algae-based cosmetics were filed between 2010 and 2023 showcasing various solutions for different skin concerns [49]. Cosmetical uses of macroalgae and microalgae ingredients can be categorized into seven major categories, including anti-aging, moisturizing, whitening, thickening, photoprotection and antioxidant and hair care [48].

3.1 Anti-aging

Aging is a complicated and multicausal phenomenon, exacerbated by extrinsic factors such as UV radiation, air pollution and smoking. It eventually results in the deterioration of skin cells which manifest dryness, dull, uneven and wrinkled [48]. Given that algae in the ocean are naturally exposed to UV radiation and oxidative stress, many bioactive compounds extracted therein, for example, polysaccharides, sulfated galactan, sulfated galactofucans, peptides, polyunsaturated fatty acid, fucoxanthine, mycosporine-like amino acids and astaxanthin were found to possess anti-oxidative and anti-aging properties [50].

Fucoidan, a type of sulfated polysaccharide primarily derived from brown algae, exhibits a range of bioactivities and deserves special attention. For instance, the fucoidan extracted from Fucus vesiculosus has been incorporated into skin care products and shown to possess anti-aging and anti-wrinkle benefits. The study suggested that the fucoidan worked by enhancing dermal fibroblast proliferation and therefore promoting collagen production [48]. Moreover, another research also showed that fucoidan extract can reduce dark circles beneath the eye, possibly by accelerating the removal of heme catabolites through upregulating the rate-limiting heme oxygenase activity [51]. The polysaccharides were also demonstrated to exhibit various other beneficial effects depending on their molecular weight and sulphation, such as anti-tumour, antioxidant, anti-coagulant, anti-thrombotic, immunomodulatory, antiviral and anti-inflammatory. In addition to F. vesiculosus, fucoidan has also been reported in various other species of brown algae, such as Dictyota spp., Ascophyllum nodosum, and Sargassum cymosum [52].

Many research groups also have reported numerous other anti-aging biocompounds that have yet to be isolated and analyzed. Most of them only reported relatively preliminary results that anti-aging biocompounds were present in either water- or organic-soluble extracts from a wide variety of different algae. Those algae concerned included Ahnfeltiopsis spp., Chlorococcum spp., Colpomenia spp., Halymenia spp., Gracilaria spp., Hydroclathrus spp., Kappaphycus spp., Laurencia spp., Macrocystis spp., Nannochloropsis spp., Nostoc spp., Polysiphonia spp., Padina spp., Turbinaria spp., just to name a few [48].

3.2 Whitening

White skin, or lighter skin colour, is commonly regarded as beauty and highly desirable, especially among women in Asian, African and Caribbean countries. It was estimated that the global market for skin whitening products will almost double from USD$ 8.8 billion in 2022 to more than 15 billion in 2030 [53], with another more ambitious estimate that it could reach as much as 31.2 billion by 2024 [54]. One of the most common approaches for skin whitening commercially, also known as skin bleaching, involves the inhibition of the copper-containing tyrosinase enzyme, thereby reducing melanin synthesis, that is, the natural dark biological pigment that gives colour, in melanocytes inside human skin. The reduction of dark pigment eventually makes the skin look whiter and lighter.

A few categories of bioactive compounds extracted from algae were shown to possess skin whitening capability. For instance, polysaccharides and their degradation products from three red algae species (Porphyra haitanensis, Gracilaria chouae and Gracilaria blodgettii) [55] and another three species of seaweed from genus Sargassum [48], bromophenols from another species of red algae (Odonthalia corymbifera) [56], polyphenols from brown algae Padina boryana [57] and fucosterol from Padina gymnospora [58] were also found to possess similar tyrosinase inhibitory capability. It is worth noting that zeaxanthin, initially extracted from the microalgae Nannochloropsis oculata, has been used in cosmetic whitening creams available on the market in the past decade [59]. The zeaxanthin could also be isolated from other microalgae, for example, some blue-green algae and red algae, in high yield [60].

3.3 Moisturizing

Moisturizers are a group of cosmetics that maintain, and better improve, the barrier function of the skin, thereby keeping its healthy appearance. Medically, they are compounds that are capable of increasing skin hydration through reducing trans-epidermal water loss from the skin surface, commonly by holding water in-situ or forming a layer of impermeable film to counteract evaporation [61].

Algae are rich in polysaccharides and oligosaccharides which are excellent in storing water, at the same time connecting to the skin keratin with hydrogen bonds [49]. Polysaccharides differ in weight and functional groups, which in turn affects their moisturizing properties. The sulfated polysaccharides isolated from a red alga (Porphyra spp.) were found to improve the maturation of the keratinized envelope and possess a strong and prolonged moisturizing effect [62]. On the other hand, lipid molecules extracted from brown macroalgae Laminaria ochroleuca contain up to 55% unsaturated fatty acids that help to regulate trans-epidermal water loss. The fatty acids were proven for their excellent moisturizing properties and are widely used in commercial skincare products [63].

3.4 Thickening

Similar to thickeners in food industries, the extracts from various geniuses of algae, mainly the polysaccharides alginate, agar and carrageenan mentioned in the previous section, could be incorporated into cosmetic formulations as a thickening agent in notions, creams, bath soap/rinse, lipsticks [7]. The algae-derived thickeners are also often marketed as natural, sustainable, and skin-friendly, distinguishing them from their counterpart which are made synthetically [48].

3.5 Photoprotection and antioxidant

Human skin is prone to damage by excessive exposure to sunlight due to the generation of reactive oxygen species, damaging DNA or other cellular components, and resulting in diverse skin problems for instance hyperpigmentation, dullness, lack of radiance, uneven skin tone, wrinkles and more [64]. Screening of ultraviolet radiation could therefore effectively avoid such damage. Furthermore, unlike mainstream chemical sunscreen using titanium and zinc oxides that cause marine pollution and intoxication, algal products are easily biodegraded and cause no harm to the environment [65]. Microalgal compounds can protect human skin through three mechanisms, either individually or in combination: first, by directly screening UV rays, second, by scavenging free radicals generated by UV exposure and third, by protecting skin cells from damage caused by these radicals [66].

Microalgae are known to produce numerous photoprotective and anti-oxidative biocompounds, for example, mycosporine-like amino acids produced by a range of algal species such as Aphanizomenon flos-aquae. The small acids are capable of absorbing and thereby screening UV radiation between 310 and 360nm from the skin [67]. Moreover, biocompounds from many other algal species, such as carotenoid, astaxanthin, phenolic compounds (e.g., phlorotannins) and polyunsaturated fatty acids were also shown to have antioxidant and photoprotection properties [68, 69]. Another study conducted by Mercurio et al. using immunohistochemical analysis also confirmed that extracts from a red alga Porphyra umbilicalis exhibited strong cell protection against DNA damage caused by ultraviolet A (UVA) radiation in mice, and hence considered an excellent alternative ingredient in sunscreen formulation [70], just to name a few. In a recent study, it was found that the extract of a green microalga Tetraselmis suecica contains a cocktail of carotenoids. The carotenoids were found capable of promoting cellular repair in reconstructed human epidermal tissue cells damaged by hydrogen peroxide treatment [71]. Today, some of the biocompounds have been adopted commercially by several companies, mostly being one of the alternative active ingredients in sunscreen products, which can provide protection up to the level of SPF 50 [66].

3.6 Hair care

The perseverance of full-head hair is getting more important, especially for males in their middle of age. Androgenetic alopecia, commonly known as hair loss disorder, is becoming not only a dermatological problem but also, if not more frustrating, a psychological nightmare. The causes of hair loss are often linked to direct contact of chemicals such as air pollutants with the hair dermis, alongside a cocktail of many other factors, including inherent genetic makeup. The root cause is often difficult to diagnose and singled out [72].

For centuries, ancient societies believed that consuming brown algae could enhance hair health. Algal ingredients primarily support hair care by protecting hair follicles. For example, studies demonstrated that algal extracts could help prevent hair loss through enzymatic and anti-inflammatory activities [73], as well as regulating androgen-induced growth factors [74]. Ex-vivo experiments from another group using mice further confirmed that the extracts from two edible brown algae possess the same hair growth effect as a typical hair loss medication (i.e., 3% minoxidil) [75]. Microalgal extracts selectively extracted using solvents from Monodus spp., Thalassiosira spp., Chaetoceros spp. and Chlorococcum spp. were already patented for cosmetics use with their outstanding properties in modulating the metabolism of human skin and hair follicles [76].

Notably, other ingredients extracted from algae, for instance, vitamin E and carotene, are often incorporated into the formula to maximize protection and healing. Today, algal extracts are marketed in some middle to high-end hair care brands, including Revlon (US), Onsensou (Japan), Nanoil (US), Mielle (P&G) and so fore.

Advertisement

4. Pharmaceutical use

Algal biocompounds are shown to provide various benefits in humans and have a high potential to be used as pharmaceuticals. Among them, some possess potent effects and/or multiple functions that with high prospects to be further developed for disease curing. These compounds have various therapeutic functions such as antimicrobial, anti-inflammatory, hypertension management, anti-cancer and aid and clinical diagnosis (Table 1). This section will explore some promising applications of algal biocompounds nowadays.

ApplicationTarget subjectBioproduct categoryActive algal bioproduct(s)Common algae (group/strain)
Anti-virusHIVPolysaccharidesSulfated polymannuro-guluronateBrown algae [77]
HIVGalactan sulfateRed algae Agardhiella tenera [78]
HIVGriffithsinRed algae Griffithsia sp. [78]
Multiple (HIV, dengue virus, common cold virus, HPV)CarrageenanRed algae [79]
SARS-CoV-2FucoidansSaccharina japonica [80]
Anti-bacteriaCommon pathogensExtractGreen algae Scenedesmus obliquus [81]
Oral pathogensExtractSulfated polysaccharide with some other chemicalsGreen alga Ulva lactuca [24]
Antibacterial (aid to stabilize Ag NPs)Gram+ve and gram −ve bacteriaPolysaccharidesSulfated polysaccharideGreen alga Ulva armoricana [82]
Anti-inflammationCarotenoids (lutein and astaxanthin), fatty acid (EPA, DHA), mycosporine-like amino acids sulfated polysaccharides [28, 83]Green algae and diatoms for example Chlorella sp., Dunaliella sp., Phaeodactylum sp., etc. [84].
Hypertension managementAngiotensin-converting enzyme activityExtract from supercritical carbon dioxide along with subcritical water extractionTotal flavonoidBrown seaweed Undaria pinnatifida [85]
Angiotensin -converting enzyme activityExtract from sequential extractionHydrolyzed products from protein-polysaccharidesBrown seaweed Saccharina latissima and Ascophyllum nodosum [86]
Cancer treatmentHuman breast cancer cell line (MCF7)PolysaccharidesPorphyranRed algae Ecklonia kurome [87]
Human breast cancer cell line (MCF7), colon cancer cell line (HT29), liver cancer cell line (HepG2) and osteosarcoma cell line (MG63)CarrageenanRed algae Kappaphycus alvarezii [88]
Human colon cancer cell line (HT29) and breast cancer cell line (T-47D)FucoidanBrown algae Alaria marginata & Alaria angusta [89]
Mice (xenograft tumour and induced colorectal cancer models)β-1,3/1,6-glucanBrown algae Durvillaea Antarctica [90]
Human liver cancer cell line (HepG2), breast cancer cell line (MCF7) and cervical cancer cell line (HeLa)UlvanGreen algae Ulva lactuca [91]
Human colon cancer cell line (HT29) and HT-29 cell-xenograft nude miceGlucuronorhamnoxylanGreen algae Capsosiphon fulvescens [92]
Breast cancer cell line (T47D) and colon cancer cell line (HT-29)Extract (hexane fraction)FucosterolBrown algae Sargassum angustifolium [93]
ATM-deficient cell line (LoVo) and KB)OthersApratoxinBlue-green algae LYNGBYA sp. [94]
Human lung cancer cell line (A549)Curacin ABlue-green algae Lyngbya majuscula [95]
Murine leukaemia cells line (L1210)Cryptophycin 1Blue-green algae Nostoc sp. [96]
Human breast cancer cell line (MCF7)Nigriccaoides A and BGreen algae Avrainvillea nigricans [97]
Cancer treatment (aids)In-situ oxygenationWhole algaeChlorella sp. [98, 99, 100]
Oral colon cancer drug deliveryWhole algaeBlue-green algae Spirulina platensis [101]
Fluorescent dyesFlow cytometry, fluorescence immuno-assay and microscopyExtract (protein purified after cell disruption, isolation and chromato-graphic separation)B-phycoerythrinRed algae Phorphyridium cruentum [102]
R-phycoerythrinRed algae Phorphyridium cruentum [102]
AllophycocyaninBlue-green algae Spirulina platensis [102]

Table 1.

An overview of pharmaceutical applications of algae.

4.1 Antimicrobial activities

4.1.1 Antiviral activities

Seaweed, that is, macroalgae, the extract had long been reported to possess a protective effect against the virus [103]. Subsequent research found that the polysaccharides therein were responsible for the antiviral properties, with some of them were proven for obstructing the infection by Human Immunodeficiency Virus (HIV) such as alginate 911 [104], sulfated polymannuro-guluronate [77], a rhodophycean galactan sulfate [78] and so forth. Carrageenan, another group of very well-researched polysaccharides from red algae, exhibits potent antiviral effects not only on HIV but also against the dengue virus, human papillomavirus (HPV) and common cold virus [79]. The study reported that the polysaccharides were capable of both improving host immunity and suppressing the virus at the same time.

Apart from HIV, other research groups also showed that algal polysaccharides exhibit strong anti-influenza capabilities [105, 106], as well as the preventive and therapeutic capabilities against SARS-CoV-2 (COVID-19) infection [107]. Kwon et al. reported that the potent antiviral capability could be a result of the polysaccharides’ exceptional binding affinity to the SARS-CoV-2’s spike protein (S-protein). The group continued to propose that the two most potent polysaccharides, that is, fucoidans and trisulfated heparin, could be further researched and developed as nasal spray, inhaler or oral drug for infection treatment [80]. Moreover, the use of algae against SARS-CoV-2 virus extended beyond direct medication. There are also attempts to develop edible vaccines using genetically modified green microalgae (Chlamydomonas reinhardtii) to produce antibodies to combat the pandemic [108].

4.1.2 Antibacterial activities

Unsurprisingly, algal extracts were also widely reported to possess antibacterial activities [109]. For example, extracts from a green alga Scenedesmus obliquus were shown to exhibit antibacterial activity against eight common pathogenic bacteria [81]. Likewise, extract from another green alga, Ulva spp. was reported to demonstrate antibacterial activity against oral pathogens. Nevertheless, their antibacterial activity could at best be rated as mild when compared to conventional antibiotics, and hence might not be a key candidate for next-generation antibiotics exploration [24]. Contrastingly, algal bioproducts stayed alive in the field as a treatment aid. A sulfated polysaccharide extracted from Ulva spp. was utilized as a stabilizer for silver nanoparticles, which together exhibited strong and fast antibacterial activities against both gram-positive and negative bacteria [82].

4.2 Anti-inflammatory

Algae, particularly microalgae, had been extensively shown to possess strong anti-inflammatory activity, alongside some other immunomodulatory properties. The activity has also been identified in a wide variety of green algae and diatoms, for example, Chlorella spp., Dunaliella spp., Phaeodactylum spp., etc. [84]. With the vast number of biocompounds involved, algal anti-inflammatory mechanisms are inevitably complex subjects to biocompounds involved. To date, isolated algal biocompounds found to have anti-inflammatory activity include carotenoids (lutein and astaxanthin), fatty acids (EPA, DHA), mycosporine-like amino acids and sulfated polysaccharides, etc. They were shown to counteracting a diverse type of inflammations from arthritis to autoimmune diseases [28, 83].

Clinically, whole algae supplement was also proven to possess anti-inflammatory activity. In medium-scale double-blind randomized trial with patients affected by non-alcoholic fatty liver disease, the group intervened with Chlorella vulgaris tablets was concluded to have significantly lower serum levels of the pro-inflammatory cytokine TNF-α, a biomarker that induces inflammation [110].

4.3 Mediation for hypertension

There are reports that extract from a brown seaweed Undaria pinnatifida possesses anti-hypertensive activities, which has the potential for use as a medication to lower blood pressure. The group also discovered that the activity was linked to the total flavonoid content levels, based on their correlation analysis [85]. Another group experimenting on another two brown algae Saccharina latissima and Ascophyllum nodosum speculated that the activity could be a result of protein-polysaccharides conjugates. When hydrolyzed, the short peptides target the angiotensin I-converting enzyme, thereby inhibiting the formation of angiotensin II [86].

It is noteworthy that other bioproducts from algae, for example, omega-3 fatty acids, antioxidants, etc., could also assist in lowering blood pressure indirectly by suppressing inflammation. Algae are also a source of both soluble and insoluble dietary fibre, which helps lower blood pressure by slowing down digestion and thus glucose absorption. There is also evidence that dietary fibre promotes fermentation that led to the production of short-chain fatty acids, which were clinically linked to a reduction in hypertension [111].

4.4 Cancer prevention or curing

Cancer prevention and curing from biocompounds isolated from algae is one of the most researched areas in the field. Decades of efforts resulted in more than a hundred such biocompounds being isolated and assayed using various different cancer cell lines (and sometimes in vivo) around the world. For example, in blue-green algae, potent anti-cancer biocompounds like apratoxin (LC50 of 0.36–0.52nM from Lyngbya sp.), curacin A (LC50 of <1 ug/mL from Lyngbya majuscule) and Cryptophycin 1 (LC50 of 1 uM from Nostoc sp.) were isolated and tested. Likewise in green algae, anti-cancer biocompounds like nigriccaoides A and B (LC50 of 3nM from Avrainvillea nigricans) and Lycopene (LC50 of 1–2 uM from Chlorella zofingiensis) had been found and assayed. Some less potent anti-cancer biocompounds can also be isolated from red and brown algae [112].

Polysaccharides are another group comprising of diverse anti-cancer biocompounds that worth particular attention. Yao and others found that almost a dozen of polysaccharides, e.g. porphyran, carrageenan, sulfated galactan, fucoidan, laminaran, β-1,3/1,6-glucan, fucan, ulvan and sulfated glucuronorhamnoxylan, exert potent anti-cancer effects against different cancer cell lines. The group further summarized that there are at least seven mechanisms involved, namely cell proliferation inhibition, apoptosis, cell cycle arrest, angiogenesis and metastasis inhibition, reactive oxygen species scavenging, immune response incitation and gut microbiota regulation [113].

Another potential candidate is fucosterol which is a water-insoluble steroid with a molecular weight of 412.7 (C29H48O). It is found commonly in brown macroalgae. Today, the steroid is mainly isolated from Sargassum spp., for example, S. angustifolium. It was reported to possess various beneficial physiological activities such as antioxidant, anti-inflammatory, anti-depressant, anti-aging, antidiabetic, cholesterol-lowering, among many others, in different in-vitro and in-vivo models [114]. In particular, there is a high potential that fucosterol could be developed as an anti-cancer drug with its potent inhibitory and cytotoxic effects against various cancer cell lines, for example, breast cancer, colon cancer, cervical cancer and lung cancer cells [115]. In a recent study, potent anti-cancer effect was observed whilst damage against normal cells was weak if not nominal. The group found that the steroid killed the cancer cells not only by inducing apoptosis, but also by downregulating essential cell cycle proteins to trigger G2/M cell cycle arrest. Similar effects were observed in their further experiment using mice as subjects, that the growth of the xenografted tumours was inhibited [116].

However, despite several anti-cancer biocompounds being identified, their clinical application as anti-cancer drugs are still in its infancy stage as most of the studies involved in-vitro and in-vivo only. To the best effort of the author, no approved anti-cancer drug available today is isolated from algae. They are hence more likely a functional food to prevent cancers [117] rather than a marketable pharmaceutical at this moment. Furthermore, and especially for polysaccharides, given the wide diversity of isomers present, more systematic research on each of them is required.

4.5 Aid in cancer therapies

Further to being developed as a drug to directly cure cancer, algae could also be used as aids in cancer therapy in a number of ways. Whereas hypoxia is a state that confers tumour tolerance and promotes invasion and metastasis, microalgae, on the other hand, are of high photosynthetic efficiency which enables them to continuously produce oxygen using carbon dioxide if a photon of the desired wavelength is provided. They are hence excellent candidates to be used for local oxygenation, providing a source of reactive oxygen for highly oxygen-dependent treatments such as radiation therapy and photodynamic therapy, thereby improving the effectiveness of those treatments [118]. In fact, some groups have already developed prototypes using live Chlorella sp. to alleviate hypoxia and curing the cancer, with encouraging outcomes in animal models [98, 99, 100].

Algae can, at the same time, be utilized as a targeted drug delivery system for cancer therapy, alongside other various diseases. Inherently, algae show strong adsorption to a variety of compounds, and their surface could be easily modified to aid drug delivery [119]. For example, the blue-green algae Spirulina is ideal for drug loading and cargo transport given their hollow microhelical structure. With their spiral structure that enhances attachment to intestinal villi, a group proved that the Spirulina platensis could act as an excellent transporter to cure colon cancer. Notably, the transporter (plus an approved anti-cancer drug) was designed to be administered orally which added much flexibility to intestinal cancer therapy. Moreover, the transporter concurrently exerted concurrently anti-inflammatory effects against colitis during the treatment [101]. Another group demonstrated that, with magnetic actuation, microswimmers synthesized using the same algae achieved both high tumour accumulation potency as well as magnetic resonance imaging properties after intravenous injection. More importantly, the microswimmer system can itself act as a photosensitizer, which generates cytotoxic reactive oxygen species, to kill the cancer cells in situ [120]. Other similar magnetic delivery systems have also been developed recently, in which the same Spirulina species was incorporated into a nanomaterial microrobot to enhance its stability in aqueous dispersions and accumulation in cancer tissues. The microrobot achieved effective target cancer ablation and is capable of killing the cells in a short period of time [121].

4.6 Fluorescent dyes for clinical diagnosis and immunological analysis

Coloured algal pigments prominently phycobiliproteins could be purified for various clinical and immunological use. These proteins play a vital role in the photosynthetic process by supplementing light absorption in wavelengths where chlorophyll is not very efficient. They are hence found abundant in many types of algae, from blue-green algae to red algae to cryptomonads. Sekar and Chandramohan summarized the various categories of phycobiliproteins presented in algae in their review [102].

Phycobiliproteins are characterized by the number and structure of their chromophores called phycobilins which are attached to their polypeptide structure. Depending on the configuration of the chromophores, the protein can capture photons at the 450–650nm range, giving them a high variety of colours and different absorption peaks for different applications [122]. Thanks to their natural involvement in the light-harvesting process, the group of proteins is reasonably stable and very soluble ideal for colorimetric use. They had been used as labels in immunoassay as early as the 1980s [123] and later marketed as diagnostic and laboratorial fluorescent dyes for more than a decade. Some commonly used and highly sensitive dyes include B-phycoerythrin, R-phycoerythrin and allophycocyanin.

Apart from clinical and immunological use, phycobiliproteins also possess multiple bioactivities such as antioxidant, antibacterial and anti-tumours, which makes them an excellent candidate in biochemical research. As discussed in Section 2, protein at the same time is an important colouring and attracted intense attention from the food and cosmetic industries [122]. According to a report from Future Market Insights, the market size of phycobiliprotein (phycocyanin) was expected to double from USD$ 754.40 million in 2022 to USD$1487.7 million in 2033 – a compound annual growth at about 7.3% [124].

Advertisement

5. Conclusion

In conclusion, this chapter has explored the multifaceted applications of algal biocompounds, demonstrating their significant potential across diverse sectors. From their historical use as a food source to their modern applications in dietary supplements and additives, algae have proven to be a valuable resource of macro- and micronutrients, natural colourings, thickeners and prebiotics. Their unique nutritional profile, coupled with their sustainable cultivation potential, positions them as key players in addressing global food security and promoting healthy diets. Furthermore, the chapter highlighted the expanding role of algae in the cosmetic industry, where their bioactive compounds are utilized for anti-aging, whitening, moisturizing, photoprotection and hair care, aligning with the growing consumer demand for natural and sustainable beauty products. Finally, the chapter delved into the promising pharmaceutical applications of algal biocompounds, showcasing their antiviral, antibacterial and anti-inflammatory activities. They also show promise in hypertension management and anti-cancer therapies, both as direct treatments and as aids like targeted drug delivery. Algal pigments also serve as valuable fluorescent dyes in clinical analysis. These findings highlight algae’s potential for future pharmaceutical development.

Advertisement

Conflict of interest

The author declares no conflict of interest.

References

  1. 1. Aaronson S. Algae. In: The Cambridge World History of Food. Cambridge: Cambridge University Press; 2000. pp. 231-249
  2. 2. Moseley ME. The Maritime Foundations of Andean Civilization; 1975
  3. 3. Sathasivam R, Radhakrishnan R, Hashem A, Abd Allah EF. Microalgae metabolites: A rich source for food and medicine. Saudi Journal of Biological Sciences. 2019;26:709-722
  4. 4. García JL, de Vicente M, Galán B. Microalgae, old sustainable food and fashion nutraceuticals. Microbial Biotechnology. 2017;10:1017-1024
  5. 5. AlFadhly NKZ, Alhelfi N, Altemimi AB, Verma DK, Cacciola F. tendencies affecting the growth and cultivation of genus spirulina: An investigative review on current trends. Plants. 2022;11:3063
  6. 6. Laamanen CA, Desjardins SM, Senhorinho GNA, Scott JA. Harvesting microalgae for health beneficial dietary supplements. Algal Research. 2021;54:102189
  7. 7. Ariede MB, Candido TM, Jacome ALM, Velasco MVR, de Carvalho JCM, Baby AR. Cosmetic attributes of algae - A review. Algal Research. 2017;25:483-487
  8. 8. Zhou Y, Liu L, Li M, Hu C. Algal biomass valorisation to high-value chemicals and bioproducts: Recent advances, opportunities and challenges. Bioresource Technology. 2022;344:126371
  9. 9. Calijuri ML, Silva TA, Magalhães IB, de Pereira ASAP, Marangon BB, de Assis LR, et al. Bioproducts from microalgae biomass: Technology, sustainability, challenges and opportunities. Chemosphere. 2022;305:135508
  10. 10. Leung EHW, Lam W, Lo CM, Lee FWF, Xu SJL. Novel Nitrogen-Doped Zinc Oxide (ND-ZnO) Algal-Bioreactor System for Methylene Blue Wastewater Treatment. Journal of Environmental Engineering. 2024;150(2):04023102. DOI: 10.1061/JOEEDU.EEENG-7409
  11. 11. Pulz O, Gross W. Valuable products from biotechnology of microalgae. Applied Microbiology and Biotechnology. 2004;65:635-648
  12. 12. Lee Y-K. Commercial production of microalgae in the Asia-Pacific rim. Journal of Applied Phycology. 1997;9:403-411
  13. 13. Liang S, Liu X, Chen F, Chen Z. Current microalgal health food R &amp; D activities in China. In: Asian Pacific Phycology in the 21st Century: Prospects and Challenges. Netherlands, Dordrecht: Springer; 2004. pp. 45-48
  14. 14. Yamaguchi K. Recent advances in microalgal bioscience in Japan, with special reference to utilization of biomass and metabolites: a review. Journal of Applied Phycology. 1996;8:487-502
  15. 15. Vanhaute E. From famine to food crisis: what history can teach us about local and global subsistence crises. Journal of Peasant Studies. 2011;38:47-65
  16. 16. Subramanian S, Sayre RT. The right stuff; realizing the potential for enhanced biomass production in microalgae. Frontiers in Energy Research. 2022;10. DOI: 10.3389/fenrg.2022.979747
  17. 17. Ullah K, Ahmad M, Sofia SVK, Lu P, Harvey A, Zafar M, et al. Algal biomass as a global source of transport fuels: Overview and development perspectives. Progress in Natural Science: Materials International. 2014;24:329-339
  18. 18. Safafar H, Uldall Nørregaard P, Ljubic A, Møller P, Løvstad Holdt S, Jacobsen C. Enhancement of Protein and Pigment Content in Two Chlorella Species Cultivated on Industrial Process Water. Journal of Marine Science and Engineering. 2016;4:84
  19. 19. AlFadhly NKZ, Alhelfi N, Altemimi AB, Verma DK, Cacciola F, Narayanankutty A. Trends and Technological Advancements in the Possible Food Applications of Spirulina and Their Health Benefits: A Review. Molecules. 2022;27:5584
  20. 20. FAO. Livestock solutions for climate change. Rome: FAO; 2017. Available from: https://www.fao.org/family-farming/detail/en/c/1634679/
  21. 21. Jareonsin S, Pumas C, Jaitiang D, Uttarotai T. Green fusion proteins: An approach to sustainable nutrition blending plant and algae-based proteins for a circular food system. Future Foods. 2024;10:100415
  22. 22. Sen TJ, Lee SY, Chew KW, Lam MK, Lim JW, Ho S-H, et al. A review on microalgae cultivation and harvesting, and their biomass extraction processing using ionic liquids. Bioengineered. 2020;11:116-129
  23. 23. Yang J, Xu M, Zhang X, Hu Q, Sommerfeld M, Chen Y. Life-cycle analysis on biodiesel production from microalgae: water footprint and nutrients balance. Bioresource Technology. 2011;102:159-165
  24. 24. Kapoor DU, Kukkar MR, Gaur M, Prajapati BG, Suttiruengwong S, Sriamornsak P. Algae as third-generation materials: Exploring the emerging role in pharmaceutical applications. Materials Today Sustainability. 2024;27:100935
  25. 25. Veerasamy V, Neethirajan V, Singarayar MS, Balasundaram D, Dharmar P, Thilagar S. Microalgal biomass and lipid synergy for omega fatty acid enrichment: A sustainable source for food supplements &amp; nutraceuticals. Algal Research. 2024;80:103514
  26. 26. Chen Z, Wu W, Wen Y, Zhang L, Wu Y, Farid MS, et al. Recent advances of natural pigments from algae. Food Production, Processing and Nutrition. 2023;5:39
  27. 27. Koh E-J, Kim K-J, Choi J, Kang D-H, Lee B-Y. Spirulina maxima extract prevents cell death through BDNF activation against amyloid beta 1-42 (Aβ 1-42) induced neurotoxicity in PC12 cells. Neuroscience Letters. 2018;673:33-38
  28. 28. Singh M, Mal N, Trivedi D, Krishnamoorthy S, Behera C, Krishnan C, et al. An overview of the role of algae-fortified foods in nutraceutical industries: Synthesis pathway of value-added bioproducts and co-products. Food Bioscience. 2025;63:105568
  29. 29. Takaichi S. Carotenoids in Algae: Distributions, Biosyntheses and Functions. Marine Drugs. 2011;9:1101-1118
  30. 30. Imchen T, Singh KS. Marine algae colorants: Antioxidant, anti-diabetic properties and applications in food industry. Algal Research. 2023;69:102898
  31. 31. Minić S, Gligorijević N, Veličković L, Nikolić M. Narrative Review of the Current and Future Perspectives of Phycobiliproteins’ Applications in the Food Industry: From Natural Colors to Alternative Proteins. International Journal of Molecular Sciences. 2024;25:7187
  32. 32. Najar-Almanzor CE, Velasco-Iglesias KD, Nunez-Ramos R, Uribe-Velázquez T, Solis-Bañuelos M, Fuentes-Carrasco OJ, et al. Microalgae-assisted green bioremediation of food-processing wastewater: A sustainable approach toward a circular economy concept. Journal of Environmental Management. 2023;345:118774
  33. 33. Chew KW, Yap JY, Show PL, Suan NH, Juan JC, Ling TC, et al. Microalgae biorefinery: High value products perspectives. Bioresource Technology. 2017;229:53-62
  34. 34. FDA. Food Additives. United States; 2004. Available from: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-170
  35. 35. Malafronte L, Yilmaz-Turan S, Krona A, Martinez-Sanz M, Vilaplana F, Lopez-Sanchez P. Macroalgae suspensions prepared by physical treatments: Effect of polysaccharide composition and microstructure on the rheological properties. Food Hydrocolloids. 2021;120:106989
  36. 36. Pradhan B, Ki J-S. Seaweed-derived laminarin and alginate as potential chemotherapeutical agents: An updated comprehensive review considering cancer treatment. International Journal of Biological Macromolecules. 2024:136593
  37. 37. Ayyakkalai B, Nath J, Rao HG, Venkata V, Nori SS, Suryanarayan S. Seaweed derived sustainable packaging. In: Applications of Seaweeds in Food and Nutrition. Netherlands: Elsevier HQ; 2024. pp. 263-287
  38. 38. Cervino G, Fiorillo L, Herford AS, et al. Alginate Materials and Dental Impression Technique: A Current State of the Art and Application to Dental Practice. Marine Drugs. 2018;17:18
  39. 39. Udo T, Mummaleti G, Mohan A, Singh RK, Kong F. Current and emerging applications of carrageenan in the food industry. Food Research International. 2023;173:113369
  40. 40. FAO. Production and Utilization of Products from Commercial Seaweeds. Rome: FAO; 1987. Available from: https://www.fao.org/4/x5822e/x5822e00.htm
  41. 41. Naseri A, Holdt SL, Jacobsen C. Biochemical and Nutritional Composition of Industrial Red Seaweed Used in Carrageenan Production. Journal of Aquatic Food Product Technology. 2019;28:967-973
  42. 42. Gotteland M, Riveros K, Gasaly N, Carcamo C, Magne F, Liabeuf G, et al. The Pros and Cons of Using Algal Polysaccharides as Prebiotics. Frontiers in Nutrition. 2020;7. DOI: 10.3389/fnut.2020.00163
  43. 43. Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology. 2020;11. DOI: 10.3389/fendo.2020.00025
  44. 44. De Jesus RM, De Morais A, De Morais R. Emergent Sources of Prebiotics: Seaweeds and Microalgae. Marine Drugs. 2016;14:27
  45. 45. Food and Drug Administration. FD&C Act. United States; 2018
  46. 46. Thiyagarasaiyar K, Goh B-H, Jeon Y-J, Yow Y-Y. Algae Metabolites in Cosmeceutical: An Overview of Current Applications and Challenges. Marine Drugs. 2020;18:323
  47. 47. Lunardo R, Saintives C. The effect of naturalness claims on perceptions of food product naturalness in the point of purchase. Journal of Retailing and Consumer Services. 2013;20:529-537
  48. 48. Saini KC, Rani A, Gupta SK, Sharma P. Algae a Potential Source in Cosmetics: Current Status, Challenges, and Economic Implications. Indian Journal of Microbiology. 2024;64: 1445-1460. DOI: 10.1007/s12088-024-01263-0
  49. 49. Hernández Muñoz AC, Rodríguez Martínez IA, Serafini MR, Aragón DM. Innovative applications of marine-derived algae in cosmetics: A patent review (2010−2023). Algal Research. 2024;84:103806
  50. 50. Michalak I, Dmytryk A, Chojnacka K. Algae Cosmetics. In: Encyclopedia of Marine Biotechnology. New Jersey, US: Wiley; 2020. pp. 65-85
  51. 51. Sun Y, Chavan M. Cosmetic Compositions Comprising Marine Plants; 2017
  52. 52. Anjana K, Arunkumar K. Brown algae biomass for fucoxanthin, fucoidan and alginate; update review on structure, biosynthesis, biological activities and extraction valorisation. International Journal of Biological Macromolecules. 2024;280:135632
  53. 53. Arora N, Amin S. Analyzing Global Interest in Skin Whitening by Geographic Region. Baylor University Medical Center Proceedings. 2024;37:505-507
  54. 54. Zhao W, Yang A, Wang J, et al. Potential application of natural bioactive compounds as skin-whitening agents: A review. Journal of Cosmetic Dermatology. 2022;21:6669-6687
  55. 55. Xie X-T, Zhang X, Liu Y, Chen X-Q, Cheong K-L. Quantification of 3,6-anhydro-galactose in red seaweed polysaccharides and their potential skin-whitening activity. 3 Biotech. 2020;10:189
  56. 56. Islam MR, Mikami D, Kurihara H. Tyrosinase inhibitory and antioxidant activity by bromophenols from the alga Odonthalia corymbifera. Natural Products an Indian Journal. 2017;13:110
  57. 57. Jayawardena TU, Sanjeewa KKA, Kim H-S, Lee HG, Wang L, Lee D-S, et al. Padina boryana, a brown alga from the Maldives: inhibition of α-MSH-stimulated melanogenesis via the activation of ERK in B16F10 cells. Fisheries and Aquatic Science. 2020;23:8
  58. 58. Kim HK, Bak J, Kang HB, Kim M-J, Kim J-M, Min K, et al. The Skin-Whitening Effects of Padina Gymnospora and Its Active Compound, Fucosterol. Journal of Life Sciences. 2020;30:598-605
  59. 59. Babitha S, Kim E-K. Effect of marine cosmeceuticals on the pigmentation of skin. Marine Cosmeceuticals: Trends and Prospects. 2011;1:63-66
  60. 60. Bourdon L, Jensen AA, Kavanagh JM, McClure DD. Microalgal production of zeaxanthin. Algal Research. 2021;55:102266
  61. 61. Draelos ZD. The science behind skin care: Moisturizers. Journal of Cosmetic Dermatology. 2018;17:138-144
  62. 62. Zhang T, Guo Q, Xin Y, Liu Y. Comprehensive review in moisture retention mechanism of polysaccharides from algae, plants, bacteria and fungus. Arabian Journal of Chemistry. 2022;15:104163
  63. 63. Otero P, López-Martínez MI, García-Risco MR. Application of pressurized liquid extraction (PLE) to obtain bioactive fatty acids and phenols from Laminaria ochroleuca collected in Galicia (NW Spain). Journal of Pharmaceutical and Biomedical Analysis. 2019;164:86-92
  64. 64. Zhang T, Ungsurungsie M, Yue L, Li J, Zhuang B, Ding W, et al. Skin photobiological effect induced by BL: Clinical manifestation, mechanisms, and protection against photodamages. Journal of Dermatologic Science and Cosmetic Technology. 2024;1:100042
  65. 65. Lozano C, Givens J, Stien D, Matallana-Surget S, Lebaron P. Bioaccumulation and Toxicological Effects of UV-Filters on Marine Species; 2020, pp. 85-130
  66. 66. Najafi A, Heidary M, Martinez RM, Baby AR, Morowvat MH. Microalgae-based sunscreens as green and sustainable cosmetic products. International Journal of Cosmetic Science. 2024. DOI: 10.1111/ics.13019
  67. 67. Karsten U, Lembcke S, Schumann R. The effects of ultraviolet radiation on photosynthetic performance, growth and sunscreen compounds in aeroterrestrial biofilm algae isolated from building facades. Planta. 2007;225:991-1000
  68. 68. Bedoux G, Hardouin K, Burlot AS, Bourgougnon N. Bioactive Components from Seaweeds; 2014, pp. 345-378
  69. 69. Maadane A, Merghoub N, El Mernissi N, Ainane T, Amzazi S, Wahby I, et al. Antimicrobial activity of marine microalgae isolated from moroccan coastlines. Journal of Microbiology, Biotechnology and Food Sciences. 2017;6:1257-1260
  70. 70. Mercurio DG, Wagemaker TAL, Alves VM, Benevenuto CG, Gaspar LR, Maia Campos PMBG. In vivo photoprotective effects of cosmetic formulations containing UV filters, vitamins, Ginkgo biloba and red algae extracts. Journal of Photochemistry and Photobiology. B. 2015;153:121-126
  71. 71. Sansone C, Galasso C, Orefice I, et al. The green microalga Tetraselmis suecica reduces oxidative stress and induces repairing mechanisms in human cells. Scientific Reports. 2017;7:41215
  72. 72. Aggarwal A, Gupta R, Thukral N, Nandi G, Bora G. Analysis of various factors responsible for hair loss and awareness level in Delhi and the National Capital Region of India. Current Science. 2020;118:786-791
  73. 73. Aslam A, Bahadar A, Liaquat R, Saleem M, Waqas A, Zwawi M. Algae as an attractive source for cosmetics to counter environmental stress. Science of the Total Environment. 2021;772:144905
  74. 74. Huang C-Y, Huang C-Y, Yang C-C, Lee T-M, Chang J-S. Hair growth-promoting effects of Sargassum glaucescens oligosaccharides extracts. Journal of the Taiwan Institute of Chemical Engineers. 2022;134:104307
  75. 75. Park KS, Park DH. Comparison of Saccharina japonica–Undaria pinnatifida mixture and minoxidil on hair growth promoting effect in mice. Archives of Plastic Surgery. 2016;43:498-505
  76. 76. Zanella L, Pertile P, Massironi M, Massironi M, Caviola E. Extracts of Microalgae and their Application; 2018
  77. 77. Meiyu G, Fuchuan L, Xianliang X, Jing L, Zuowei Y, Huashi G. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry Interaction between SPMG and HIV-1 rgp120 and CD4 molecule. Antiviral Research. 2003;59:127-135
  78. 78. Yasuhara-Bell J, Lu Y. Marine compounds and their antiviral activities. Antiviral Research. 2010;86:231-240
  79. 79. Grassauer A, Weinmuellner R, Meier C, Pretsch A, Prieschl-Grassauer E, Unger H. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virology Journal. 2008;5:107
  80. 80. Kwon PS, Oh H, Kwon S-J, Jin W, Zhang F, Fraser K, et al. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro. Cell Discover. 2020;6:50
  81. 81. Bastia AK. In vitro antioxidant and antibacterial activity of Scenedesmus obliquus collected from Similipal biosphere reserve, Odisha, India. Journal of Indian Botanical Society. 2022;102:218-228
  82. 82. Massironi A, Morelli A, Grassi L, Puppi D, Braccini S, Maisetta G, et al. Ulvan as novel reducing and stabilizing agent from renewable algal biomass: Application to green synthesis of silver nanoparticles. Carbohydrate Polymers. 2019;203:310-321
  83. 83. Montero-Lobato Z, Vázquez M, Navarro F, Fuentes JL, Bermejo E, Garbayo I, et al. Chemically-Induced Production of Anti-Inflammatory Molecules in Microalgae. Marine Drugs. 2018;16:478
  84. 84. Tabarzad M, Atabaki V, Hosseinabadi T. Anti-inflammatory Activity of Bioactive Compounds from Microalgae and Cyanobacteria by Focusing on the Mechanisms of Action. Molecular Biology Reports. 2020;47:6193-6205
  85. 85. Kim S-Y, Roy VC, Park J-S, Chun B-S. Extraction and characterization of bioactive compounds from brown seaweed (Undaria pinnatifida) sporophyll using two sequential green extraction techniques. Algal Research. 2024;77:103330
  86. 86. Bojorges H, López-Rubio A, Martínez-Abad A, Fabra MJ. Functional and bioactive properties of the protein-polysaccharide extracts from brown algae: Exploring novel functional ingredients. Food Hydrocolloids. 2025;162:110967
  87. 87. Li Y, Qin G, Cheng C, Yuan B, Huang D, Cheng S, et al. Purification, characterization and anti-tumor activities of polysaccharides from Ecklonia kurome obtained by three different extraction methods. International Journal of Biological Macromolecules. 2020;150:1000-1010
  88. 88. Suganya AM, Sanjivkumar M, Chandran MN, Palavesam A, Immanuel G. Pharmacological importance of sulphated polysaccharide carrageenan from red seaweed Kappaphycus alvarezii in comparison with commercial carrageenan. Biomedicine and Pharmacotherapy. 2016;84:1300-1312
  89. 89. Usoltseva (Menshova) R V, Anastyuk SD, Shevchenko NM, Zvyagintseva TN, Ermakova SP. The comparison of structure and anticancer activity in vitro of polysaccharides from brown algae Alaria marginata and A. angusta. Carbohydrate Polymers. 2016;153:258-265
  90. 90. Su F, Song Q, Zhang C, et al. A β-1,3/1,6-glucan from Durvillaea Antarctica inhibits tumor progression in vivo as an immune stimulator. Carbohydrate Polymers. 2019;222:114993
  91. 91. Thanh TTT, Quach TMT, Nguyen TN, Vu Luong D, Bui ML, Van TTT. Structure and cytotoxic activity of ulvan extracted from green seaweed Ulva lactuca. International Journal of Biological Macromolecules. 2016;93:695-702
  92. 92. Choi JW, Lee J, Kim SC, You S, Lee CW, Shin J, et al. Glucuronorhamnoxylan from Capsosiphon fulvescens inhibits the growth of HT-29 human colon cancer cells in vitro and in vivo via induction of apoptotic cell death. International Journal of Biological Macromolecules. 2019;124:1060-1068
  93. 93. Ostad S, Khanavi M, Gheidarloo R, Sadati N, Ardekani MR, Nabavi SB, et al. Cytotoxicity of fucosterol containing fraction of marine algae against breast and colon carcinoma cell line. Pharmacognosy Magazine. 2012;8:60
  94. 94. Luesch H. New apratoxins of marine cyanobacterial origin from guam and palau. Bioorganic & Medicinal Chemistry. 2002;10:1973-1978
  95. 95. Catassi A, Cesario A, Arzani D, Menichini P, Alama A, Bruzzo C, et al. Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells. Cellular and Molecular Life Sciences. 2006;63:2377-2386
  96. 96. Foster BJ, Fortuna M, Media J, Wiegand RA, Valeriote FA. Cryptophycin 1 cellular levels and effects in vitro using L1210 cells. Investigational New Drugs. 1998;16:199-204
  97. 97. Williams DE, Sturgeon CM, Roberge M, Andersen RJ. Nigricanosides A and B, Antimitotic Glycolipids Isolated from the Green Alga Avrainvillea nigricans Collected in Dominica. Journal of the American Chemical Society. 2007;129:5822-5823
  98. 98. Lee C, Lim K, Kim SS, Thien LX, Lee ES, Oh KT, et al. Chlorella-gold nanorods hydrogels generating photosynthesis-derived oxygen and mild heat for the treatment of hypoxic breast cancer. Journal of Controlled Release. 2019;294:77-90
  99. 99. Zhong D, Li W, Hua S, Qi Y, Xie T, Qiao Y, et al. Calcium phosphate engineered photosynthetic microalgae to combat hypoxic-tumor by in-situ modulating hypoxia and cascade radio-phototherapy. Theranostics. 2021;11:3580-3594
  100. 100. Wang H, Guo Y, Wang C, Jiang X, Liu H, Yuan A, et al. Light-controlled oxygen production and collection for sustainable photodynamic therapy in tumor hypoxia. Biomaterials. 2021;269:120621
  101. 101. Zhong D, Zhang D, Chen W, He J, Ren C, Zhang X, et al. Orally deliverable strategy based on microalgal biomass for intestinal disease treatment. Science Advances. 2021;7(48). DOI: 10.1126/sciadv.abi9265
  102. 102. Sekar S, Chandramohan M. Phycobiliproteins as a commodity: trends in applied research, patents and commercialization. Journal of Applied Phycology. 2008;20:113-136
  103. 103. Gerber P, Dutcher JD, Adams EV, Sherman JH. Protective Effect of Seaweed Extracts for Chicken Embryos Infected with Influenza B or Mumps Virus. Experimental Biology and Medicine. 1958;99:590-593
  104. 104. Besednova NN, Zvyagintseva TN, Kuznetsova TA, Makarenkova ID, Smolina TP, Fedyanina LN, et al. Marine Algae Metabolites as Promising Therapeutics for the Prevention and Treatment of HIV/AIDS. Metabolites. 2019;9:87
  105. 105. Kanekiyo K, Hayashi K, Takenaka H, Lee J-B, Hayashi T. Anti-herpes Simplex Virus Target of an Acidic Polysaccharide, Nostoflan, from the Edible Blue-Green Alga Nostoc flagelliforme. Biological & Pharmaceutical Bulletin. 2007;30:1573-1575
  106. 106. Wang W, Wang S-X, Guan H-S. The Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview. Marine Drugs. 2012;10:2795-2816
  107. 107. Alam MA, Parra-Saldivar R, Bilal M, Afroze CA, Ahmed MN, Iqbal HMN, et al. Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2. Molecules. 2021;26:2134
  108. 108. Sami N, Ahmad R, Fatma T. Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2. Biomedical Journal. 2021;44:54-62
  109. 109. Salvador N, Garreta AG, Lavelli L, Ribera MA. Antimicrobial activity of Iberian macroalgae. Scientia Marina. 2007;71:101-114
  110. 110. Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, Vaghef-Mehrabany E, Aliashrafi S. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris : A double-blind placebo-controlled randomized clinical trial. Clinical Nutrition. 2017;36:1001-1006
  111. 111. Tejani VN, Dhillon SS, Damarlapally N, Usman NUB, Winson T, Basu Roy P, et al. The Relationship Between Dietary Fiber Intake and Blood Pressure Worldwide: A Systematic Review. Cureus. 2023;15(9):e46116. DOI: 10.7759/cureus.46116
  112. 112. Minhas LA, Kaleem M, Farooqi HMU, Kausar F, Waqar R, Bhatti T, et al. Algae-derived bioactive compounds as potential pharmaceuticals for cancer therapy: A comprehensive review. Algal Research. 2024;78:103396
  113. 113. Yao W, Qiu H-M, Cheong K-L, Zhong S. Advances in anti-cancer effects and underlying mechanisms of marine algae polysaccharides. International Journal of Biological Macromolecules. 2022;221:472-485
  114. 114. Hannan MA, Sohag AAM, Dash R, Haque MN, Mohibbullah M, Oktaviani DF, et al. Phytosterols of marine algae: Insights into the potential health benefits and molecular pharmacology. Phytomedicine. 2020;69:153201
  115. 115. Zhou J, Wang M, Pallarés N, Ferrer E, Berrada H, Barba FJ. Sterols and fat-soluble vitamins. In: Food Lipids. Netherlands: Elsevier; 2022. pp. 323-348
  116. 116. Mao Z, Shen X, Dong P, Liu G, Pan S, Sun X, et al. Fucosterol exerts antiproliferative effects on human lung cancer cells by inducing apoptosis, cell cycle arrest and targeting of Raf/MEK/ERK signalling pathway. Phytomedicine. 2019;61:152809
  117. 117. Raman M, Doble M. κ-Carrageenan from marine red algae, Kappaphycus alvarezii – A functional food to prevent colon carcinogenesis. Journal of Functional Foods. 2015;15:354-364
  118. 118. Han D, Zhang X, Ma Y, Yang X, Li Z. The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy. Materials Today Bio. 2023;18:100517
  119. 119. Xin Z, Zhang M, Cui H, Ding X, Zhang T, Wu L, et al. Algae: A Robust Living Material Against Cancer. International Journal of Nanomedicine. 2023;18:5243-5264
  120. 120. Zhong D, Li W, Qi Y, He J, Zhou M. Photosynthetic Biohybrid Nanoswimmers System to Alleviate Tumor Hypoxia for FL/PA/MR Imaging-Guided Enhanced Radio-Photodynamic Synergetic Therapy. Advanced Functional Materials. 2020;30(17). DOI: 10.1002/adfm.201910395
  121. 121. de la Asunción-Nadal V, Franco C, Veciana A, et al. MoSBOTs: Magnetically Driven Biotemplated MoS 2-Based Microrobots for Biomedical Applications. Small. 2022;18(33):2203821. DOI: 10.1002/smll.202203821
  122. 122. Dagnino-Leone J, Figueroa CP, Castañeda ML, Youlton AD, Vallejos-Almirall A, Agurto-Muñoz A, et al. Phycobiliproteins: Structural aspects, functional characteristics, and biotechnological perspectives. Computational and Structural Biotechnology Journal. 2022;20:1506-1527
  123. 123. Kronick MN. The use of phycobiliproteins as fluorescent labels in immunoassay. Journal of Immunological Methods. 1986;92:1-13
  124. 124. Future Market Insights Inc. Global Phycocyanin Market Snapshot (2023 to 2033); 2023. Available from: https://www.futuremarketinsights.com/reports/phycocyanin-market [Accessed: December 30, 2024]

Written By

Edwin H.W. Leung

Submitted: 07 January 2025 Reviewed: 04 February 2025 Published: 13 March 2025

© The Author(s). Licensee IntechOpen. This content is distributed under the terms of the Creative Commons 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Current and Prospective Pharmaceutical Use of Algal Bioproducts (2025)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Carlyn Walter

Last Updated:

Views: 6172

Rating: 5 / 5 (70 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Carlyn Walter

Birthday: 1996-01-03

Address: Suite 452 40815 Denyse Extensions, Sengermouth, OR 42374

Phone: +8501809515404

Job: Manufacturing Technician

Hobby: Table tennis, Archery, Vacation, Metal detecting, Yo-yoing, Crocheting, Creative writing

Introduction: My name is Carlyn Walter, I am a lively, glamorous, healthy, clean, powerful, calm, combative person who loves writing and wants to share my knowledge and understanding with you.